Raymond J. Bartoszek - Net Worth and Insider Trading
Raymond J. Bartoszek Net Worth
The estimated net worth of Raymond J. Bartoszek is at least $588,256 dollars as of 2024-11-05. Raymond J. Bartoszek is the Director of Kineta Inc and owns about 863,685 shares of Kineta Inc (KANT) stock worth over $588,256. Details can be seen in Raymond J. Bartoszek's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Raymond J. Bartoszek has not made any transactions after 2023-12-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Raymond J. Bartoszek
Raymond J. Bartoszek Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Raymond J. Bartoszek owns 2 companies in total, including Yumanity Therapeutics Inc (YMTX) , and Kineta Inc (KANT) .
Click here to see the complete history of Raymond J. Bartoszek’s form 4 insider trades.
Insider Ownership Summary of Raymond J. Bartoszek
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| YMTX | Yumanity Therapeutics Inc | 2022-12-16 | director |
| KANT | Kineta Inc | 2023-12-06 | director |
Raymond J. Bartoszek Latest Holdings Summary
Raymond J. Bartoszek currently owns a total of 1 stock. Raymond J. Bartoszek owns 863,685 shares of Kineta Inc (KANT) as of December 6, 2023, with a value of $588,256.
Latest Holdings of Raymond J. Bartoszek
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KANT | Kineta Inc | 2023-12-06 | 863,685 | 0.68 | 588,256 |
Holding Weightings of Raymond J. Bartoszek
Raymond J. Bartoszek Form 4 Trading Tracker
According to the SEC Form 4 filings, Raymond J. Bartoszek has made a total of 3 transactions in Kineta Inc (KANT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Kineta Inc is the acquisition of 2,250 shares on December 6, 2023, which cost Raymond J. Bartoszek around $9,945.
Insider Trading History of Raymond J. Bartoszek
- 1
Raymond J. Bartoszek Trading Performance
GuruFocus tracks the stock performance after each of Raymond J. Bartoszek's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Raymond J. Bartoszek is 17.01%. GuruFocus also compares Raymond J. Bartoszek's trading performance to market benchmark return within the same time period. The performance of stocks bought by Raymond J. Bartoszek within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Raymond J. Bartoszek's insider trading performs compared to the benchmark.
Performance of Raymond J. Bartoszek
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 25.41 | | | | | |
| Relative Return to S&P 500(%) | 26.61 | | | | | |
Raymond J. Bartoszek Ownership Network
Ownership Network List of Raymond J. Bartoszek
Ownership Network Relation of Raymond J. Bartoszek
Raymond J. Bartoszek Owned Company Details
What does Yumanity Therapeutics Inc do?
Who are the key executives at Yumanity Therapeutics Inc?
Raymond J. Bartoszek is the director of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , Chief Scientific Officer Thierry Guillaudeux , and Chief Financial Officer Keith Baker .
Yumanity Therapeutics Inc (YMTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Yumanity Therapeutics Inc Insider Transactions
Raymond J. Bartoszek Mailing Address
Above is the net worth, insider trading, and ownership report for Raymond J. Bartoszek. You might contact Raymond J. Bartoszek via mailing address: C/o Kineta, Inc., 219 Terry Ave. N., Suite 300, Seattle Wa 98109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
